Patent Assignment
Reel/Frame 052321/0294
Assignment of Assignor's Interest
Recorded: 2020-04-06
Pages: 73
Assignor
APEIRON BIOLOGICS AG
Executed: 2016-09-27
Assignee
EUSA PHARMA (UK) LIMITED
BREAKSPEAR PARK, BREAKSPEAR WAY, HEMEL HEMPTSTEAD, HP24TZ, UNITED KINGDOM
Covered Property
(1)
Method for Treating a GD2 Positive Cancer
Application:
16/375,022 →
Publication:
US 2020/0055953
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 6, 2020
From: LOIBNER, HANS; MUTSCHLECHNER, OLIVER; LADENSTEIN, RUTH; KLIER, ISABEL
To: APEIRON BIOLOGICS AG
Reel/Frame 052320/0973 →
Corrective Assignment to Correct the Nature of Conveyance from Assignment to License Agreement Previously Recorded at Reel: 52321 Frame: 294. Assignor(S) Hereby Confirms the License Agreement
May 14, 2020
From: APEIRON BIOLOGICS AG
To: EUSA PHARMA (UK) LIMITED
Reel/Frame 052666/0575 →